Wei Jin
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 9
- Breast Cancer Treatment Studies 7
- Cancer, Hypoxia, and Metabolism 6
- Oncology top 5%
- Cancer Cells and Metastasis 9
- Pancreatic and Hepatic Oncology Research 5
- Molecular Biology top 10%
- RNA modifications and cancer 6
- DNA Repair Mechanisms 5
- Ubiquitin and proteasome pathways 5
- Co-authors
- Hefen SunLiangdong LiJiong WuShuiping GaoYang ZhaoWenyan FuZhi‐Ming ShaoXianjun Yu
- Journals
- Cancer Medicine (5 papers)Breast Cancer Research and Treatment (5 papers)Acta Biochimica et Biophysica Sinica (5 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Wei Jin
68 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 100
- Cancer Research 523
- Oncology 577
- Molecular Biology 1.0k
- Immunology 182
- Pulmonary and Respiratory Medicine 262
Countries citing papers authored by Wei Jin
This map shows the geographic impact of Wei Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Jin more than expected).
Fields of papers citing papers by Wei Jin
This network shows the impact of papers produced by Wei Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Jin. The network helps show where Wei Jin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 5 | |
| 3 | 2022 | 16 | |
| 4 | 2022 | 7 | |
| 5 | 2022 | 38 | |
| 6 | 2022 | 13 | |
| 7 | 2021 | 29 | |
| 8 | 2021 | 8 | |
| 9 | 2019 | 8 | |
| 10 | 2019 | 74 | |
| 11 | 2019 | 42 | |
| 12 | 2018 | 23 | |
| 13 | 2018 | 14 | |
| 14 | 2017 | 11 | |
| 15 | 2015 | 20 | |
| 16 | Effects of berberine on insulin resistance and serum adiponectin of nonalcoholic fatty liver patients | 2011 | 6 |
| 17 | 2010 | 16 | |
| 18 | 2009 | 10 | |
| 19 | 2009 | 34 | |
| 20 | 2003 | 2 |
About Wei Jin
Wei Jin is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 72 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (9 papers), Cancer-related molecular mechanisms research (9 papers), Breast Cancer Treatment Studies (7 papers), Cancer, Hypoxia, and Metabolism (6 papers), RNA modifications and cancer (6 papers), DNA Repair Mechanisms (5 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Cancer Research (523 citations), Oncology (577 citations), Molecular Biology (1.0k citations), Immunology (182 citations) and Pulmonary and Respiratory Medicine (262 citations). Wei Jin has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Hefen Sun, Liangdong Li, Jiong Wu, Shuiping Gao, Yang Zhao, Wenyan Fu, Zhi‐Ming Shao, Xianjun Yu, Hua-Xiang Xu and Jin-Zhi Xu. Their work appears in journals such as Cancer Medicine, Breast Cancer Research and Treatment, Acta Biochimica et Biophysica Sinica, Theranostics and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.